Shanna Fuld

About the Author Shanna Fuld

Shanna J. Fuld is a journalist specializing in the cannabis market. Fascinated by the industry's growth, she quickly started making contacts in the cannabis world internationally and loves writing about the nuances of the field. The former NY1er worked as a videographer, assignment editor and writer for the beloved local news channel before joining the TipRanks team.

This Analyst Cheers for AcelRx (ACRX), the Little Opioid Company that Could

Drug company AcelRx (ACRX) is likely celebrating its first win after getting news from the Food and Drug Administration (FDA) late Friday afternoon …

This Top Analyst Bets on Netflix (NFLX) Stock Ahead of Earnings, Should You?

It’s been a bit of a roller coaster for Netflix (NFLX) backers and even though the video streaming service’s stock price has fallen …

Spooked Investors Send Trevena (TVRN) Stock Spiraling as the Company’s Lead Drug Candidate Faces Major Downfall

The US Food and Drug Administration (FDA) puts the needle in the arm of drug company Trevena (TRVN). The agency’s critical briefing documents …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts